Literature DB >> 17283433

The role of simvastatin on postoperative peritoneal adhesion formation in an animal model.

Hasan Fehmi Kucuk1, Levent Kaptanoglu, Necmi Kurt, Huseyin Uzun, Mehmet Eser, Sadik Bingul, Oguzhan Aziz Torlak, Huseyin Akyol.   

Abstract

AIM: The aim of this study is to show the effect of simvastatin on intra-abdominal adhesion formation.
METHOD: Adhesion formation was achieved by scratching the cecum and anterior abdominal wall following median laparotomy. Three different groups of 10 rats each were formed. In group I, 0.57 mg/kg/day simvastatin was injected intraperitoneally right after the operation and for 5 days thereafter. In group II, an equal dose of simvastatin to that used in group I was given via gavage. A physiological saline solution was given to group III for the same period of time. On the 6th and 14th day, blood samples were taken and peritoneal lavage was performed to measure the tissue-type plasminogen activator (t-PA) activity. Adhesions were graded via re-laparotomies on the 14th day after the first operation.
RESULTS: The adhesion scores were 1.40 +/- 0.22, 1.50 +/- 0.26, and 2.90 +/- 0.34 in groups I, II, and III, respectively (p = 0.007), and the score was higher in group III than in the other groups (p = 0.005, p = 0.011).
CONCLUSION: Intraperitoneal simvastatin application decreases adhesion formation by increasing the t-PA level in abdominal surgery. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17283433     DOI: 10.1159/000099156

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  8 in total

Review 1.  Current strategies and future perspectives for intraperitoneal adhesion prevention.

Authors:  Christoph Brochhausen; Volker H Schmitt; Constanze N E Planck; Taufiek K Rajab; David Hollemann; Christine Tapprich; Bernhard Krämer; Christian Wallwiener; Helmut Hierlemann; Rolf Zehbe; Heinrich Planck; C James Kirkpatrick
Journal:  J Gastrointest Surg       Date:  2012-06       Impact factor: 3.452

2.  Postoperative peritoneal adhesion: an update on physiopathology and novel traditional herbal and modern medical therapeutics.

Authors:  Setareh Soltany
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-09-26       Impact factor: 3.000

3.  An FDA approved neurokinin-1 receptor antagonist is effective in reducing intraabdominal adhesions when administered intraperitoneally, but not orally.

Authors:  Rizal Lim; Jonathan M Morrill; Scott G Prushik; Karen L Reed; Adam C Gower; Susan E Leeman; Arthur F Stucchi; James M Becker
Journal:  J Gastrointest Surg       Date:  2008-08-16       Impact factor: 3.452

4.  Effects of Intraperitoneal Administration of Simvastatin in Prevention of Postoperative Intra-abdominal Adhesion Formation in Animal Model of Rat.

Authors:  Mojtaba Javaherzadeh; Ali Shekarchizadeh; Marjan Kafaei; Abass Mirafshrieh; Nariman Mosaffa; Babak Sabet
Journal:  Bull Emerg Trauma       Date:  2016-07

5.  Reduction of postsurgical adhesions in a rat model: a comparative study.

Authors:  Oktay Irkorucu; Zafer Ferahköşe; Leyla Memiş; Ozgür Ekinci; Murat Akin
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

6.  Effect of Hypericum perforatum on intraperitoneal adhesion formation in rats.

Authors:  Deniz Hızlı; Fatih Hızlı; Aydın Köşüş; Saynur Yılmaz; Nermin Köşüş; Hacer Haltaş; Hülya Dede; Hasan Kafalı
Journal:  Arch Med Sci       Date:  2013-02-18       Impact factor: 3.318

7.  Intraperitoneal administration of rosuvastatin prevents postoperative peritoneal adhesions by decreasing the release of tumor necrosis factor.

Authors:  Stefan Chiorescu; Octavian Aurel Andercou; Nicolae Ovidiu Grad; Ion Aurel Mironiuc
Journal:  Clujul Med       Date:  2018-01-15

8.  Effect of statins on experimental postoperative adhesion: a systematic review and meta-analysis.

Authors:  Geun Joo Choi; Hee Kyung Park; Dong Su Kim; Donghyun Lee; Hyun Kang
Journal:  Sci Rep       Date:  2018-10-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.